Mary Ann Gray Elected to GTC Biotherapeutics Board of Directors

FRAMINGHAM, Mass.--(BUSINESS WIRE)--GTC Biotherapeutics, Inc. (“GTC”, Nasdaq: GTCB) announced that Mary Ann Gray, Ph.D. of Gray Strategic Advisors, LLC has been elected to its Board of Directors. GTC’s Board now has a total of eleven directors.